Written by Wells Fargo as an Equity Research piece on April 17, 2023.
TIMELINE
May2023 - Not so fast! The FTC is taking a closer look at M&A antitrust.
The FTC has asked Globus Medical and Nuvasive to provide more information about the merger, including information about their market share, their pricing practices, and their research and development activities. The FTC is also considering whether the merger would harm patients by reducing their choices of doctors and hospitals.
The FTC is expected to make a decision on whether to approve the merger within the next few months. If the FTC does not approve the merger, it could block the deal and prevent Globus Medical and Nuvasive from merging.
Here are some additional details about the FTC's review of the merger:
The FTC's review is being conducted under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
The FTC has 30 days from the date of the merger announcement to request additional information from Globus Medical and Nuvasive.
The FTC can also request that the companies delay the closing of the merger.
The FTC has 90 days from the date of the merger announcement to make a decision on whether to approve the merger....
